The use of functional quantitative biomarkers extracted from routine PET–CT scans to
characterize clinical responses in patients with lymphoma is gaining increased attention …

Purpose We aimed to determine whether the pan-immune-inflammation value (PIV) of
patients with Merkel cell carcinoma (MCC) at primary diagnosis differs from controls and …

Identification of new prognostic factors in relapsed/refractory (rel/ref) diffuse large B-cell
lymphoma (DLBCL) is essential for developing risk-adapted approaches. We retrospectively …

Purpose: Significant progress has occurred in developing quantitative PET/CT biomarkers in
diffuse large B-cell lymphoma (DLBCL). Total metabolic tumor volume (MTV) is the most …

Objective The diagnostic performance of 18 F-FDG PET for detecting regional lymph node
metastasis in resectable lung cancer is variable, and its sensitivity for adenocarcinoma is …

Objective The performance of 18 F-FDG PET-based radiomics and deep learning in
detecting pathological regional nodal metastasis (pN+) in resectable lung adenocarcinoma …

Simple Summary Patients with advanced epidermal growth factor receptor (EGFR)-mutated
lung adenocarcinoma have been known to respond to first-line tyrosine kinase inhibitor (TKI) …

Objective We investigated whether glycolytic heterogeneity correlated with histopathology,
and further stratified the survival outcomes pertaining to resectable lung adenocarcinoma …

Laryngeal carcinoma (LC) is the second most common malignant tumor of the head and
neck. Due to its insidious nature, most patients have developed to the middle and late …

Purpose To evaluate the safety, tolerability, pharmacodynamics (PD), and potential efficacy
of zosuquidar (Zos) in combination with daunorubicin and cytarabine in elderly patients with …